Statistics from Altmetric.com
Cervical screening is a highly effective way to reduce the rate of cervical cancer, which is one of the leading causes of death in young women.1 The 2001 Bethesda System divides premalignant glandular lesions into atypical glandular cells (AGC), AGC favour neoplasia and adenocarcinoma in situ. Screening guidelines have typically assigned higher priority to these lesions because of their association with increased rates of gynaecologic malignancy.2 The Taiwanese annual cervical screening programme was launched in 1995, and investigators have analysed this database in order to better categorise the risks associated with AGC.
This is a large retrospective cohort trial of Taiwanese …
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.